Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Colossal Biosciences Colossal Biosciences’ Thylacine Gene-Editing Technologies Provide Hope for Australia’s Endangered Northern Quoll May 08, 2024 From Colossal Biosciences Via Business Wire Plastic Degradation Company, Breaking, Emerges from Stealth with Naturally-Derived Solution to Degrade Multiple Plastics with $10.5M in Seed Funding April 17, 2024 From Colossal Biosciences Via Business Wire Re:wild and Colossal Biosciences team up to leverage revolutionary technology to save critically endangered species on the brink of extinction March 28, 2024 From Colossal Biosciences Via Business Wire World-Renowned Ancient DNA Expert, HHMI Investigator, and MacArthur Award Winner Beth Shapiro, Ph.D., Joins Colossal as Chief Science Officer March 19, 2024 From Colossal Biosciences Via Business Wire Revolutionary Elephant iPSC Milestone Reached in Colossal’s Woolly Mammoth Project March 06, 2024 From Colossal Biosciences Via Business Wire Oscar-Award Winning ‘My Octopus Teacher’ Nature Documentarian James Reed to Make Docuseries About De-Extinction Company Colossal, to be Produced by Underdog Films and Teton Ridge Entertainment February 21, 2024 From Colossal Biosciences Via Business Wire Colossal Biosciences Names Emily Castel as Chief Marketing Officer February 01, 2024 From Colossal Biosciences Via Business Wire Colossal Announces the Tasmania Thylacine Advisory Committee December 20, 2023 From Colossal Biosciences Via Business Wire Mauritian Wildlife Foundation Partners With Colossal Biosciences to Rewild the Dodo to Its Native Habitat November 22, 2023 From Colossal Biosciences Via Business Wire Colossal Biosciences and Save the Elephants Debut First-of-its-Kind Project to Utilize Drones and Machine Learning for Elephant Conservation November 09, 2023 From Colossal Biosciences Via Business Wire Colossal Biosciences Joins BioRescue in Its Mission to Save the Northern White Rhino From Extinction September 19, 2023 From Colossal Biosciences Via Business Wire Colossal Biosciences “Mammoth in the Classroom” Initiative, as Part of University of Alaska Fairbanks Adopt a Mammoth Program, Has Reached Its Initial Research and Adoption Goal August 21, 2023 From Colossal Biosciences Via Business Wire Colossal Biosciences Launches Partnership with Elephant Havens Wildlife Foundation to Develop New Models for the Successful Reintroduction of Orphan Elephants Using AI July 19, 2023 From Colossal Biosciences Via Business Wire Colossal Biosciences Named to TIME’s List of the TIME100 Most Influential Companies June 21, 2023 From Colossal Biosciences Via Business Wire Colossal Biosciences and the Vertebrate Genomes Project Publish the First Near Complete African Elephant Chromosome Level Genome May 18, 2023 From Colossal Biosciences Via Business Wire Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo January 31, 2023 From Colossal Biosciences Via Business Wire Colossal Accelerates Research and Development of Life-Saving Vaccine to Prevent Elephant Extinction October 05, 2022 From Colossal Biosciences Via Business Wire Colossal Biosciences Spins Out Form Bio to Revolutionize Computational Life Sciences September 27, 2022 From Colossal Biosciences Via Business Wire Colossal to De-Extinct the Thylacine, also known as the Tasmanian Tiger, an Iconic Australian Marsupial That Has Been Extinct Since 1936 August 16, 2022 From Colossal Biosciences Via Business Wire Colossal Biosciences and the Vertebrate Genomes Project Sequence the Asian Elephant Genome, Chromosome to Chromosome July 12, 2022 From Colossal Biosciences Via Business Wire Colossal Named a Technology Pioneer by World Economic Forum May 10, 2022 From Colossal Biosciences Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.